The privately owned Promidis, part of the IRBM Group, is focused on the identification of innovative drugs in high unmet medical need areas, and, as a partner research organization, on offering a highly competitive spectrum of drug discovery (DD) and process chemistry (PC) activities. Promidis was established in 2013, within the IRBM Science Park in Pomezia (Rome), and then relocated in November 2015 to the San Raffaele Hospital Science Park (SRSI), in Milan.